Flavya™ Post Treatment Occlusive Patch

Flavya™ Post Treatment Occlusive Patch is a medical device in the form of a biocellulose dressing soaked in hyaluronic acid, available in two sizes:

  • 10 × 10 cm
  • 10 × 20 cm.
 
It is intended for use on specific areas of the body, such as the neck, décolletage, perioral area, and hands.

Due to its occlusive properties, the dressing forms a protective barrier on the skin, which is particularly important following esthetic medicine treatments. In addition, it provides a cooling effect, helping to soothe irritation and reduce swelling. The medical device is suitable for all skin types.

Composition: Biocellulose, Sodium Hyaluronate. Excipients: Glycereth-26, 1,2-Hexanediol, Hydroxyethyl Acrylate / Sodium Acryloyldimethyl Taurate Copolymer, Caprylyl Glycol, Ethylhexylglycerin, Onsen-Sui (aqua).

Protection, soothing and cooling of damaged and irritated skin after medical esthetic treatments. The medical device should not be used in patients with known hypersensitivity to any of the product’s ingredients.

Description

Flavya™ Post Treatment Occlusive Patch is a medical device in the form of a biocellulose dressing soaked in hyaluronic acid, available in two sizes:

  • 10 × 10 cm
  • 10 × 20 cm.
 
It is intended for use on specific areas of the body, such as the neck, décolletage, perioral area, and hands.

Due to its occlusive properties, the dressing forms a protective barrier on the skin, which is particularly important following esthetic medicine treatments. In addition, it provides a cooling effect, helping to soothe irritation and reduce swelling. The medical device is suitable for all skin types.

Specification

Composition: Biocellulose, Sodium Hyaluronate. Excipients: Glycereth-26, 1,2-Hexanediol, Hydroxyethyl Acrylate / Sodium Acryloyldimethyl Taurate Copolymer, Caprylyl Glycol, Ethylhexylglycerin, Onsen-Sui (aqua).

Indications

Protection, soothing and cooling of damaged and irritated skin after medical esthetic treatments. The medical device should not be used in patients with known hypersensitivity to any of the product’s ingredients.

Files